Survey of ophthalmology最新文献_第5页

Response to Letter to the Editor by Professor Axel Petzold 对Axel Petzold教授给编辑的信的回应。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-06 DOI: 10.1016/j.survophthal.2025.02.007

Elham Sadeghi, Jay Chhablani

引用次数: 0

Ocular manifestations secondary to cocaine abuse 可卡因滥用后的眼部表现——综述：可卡因滥用的眼部并发症。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-05 DOI: 10.1016/j.survophthal.2025.02.004

Kaersti L. Rickels , Ramsey Ghaleb , Abdelrahman M. Elhusseiny , Muhammad Z. Chauhan , Joseph Toma , Tony Wang , Daniel Cheng , Asim Ali , Ahmed B. Sallam

{"title":"Ocular manifestations secondary to cocaine abuse","authors":"Kaersti L. Rickels , Ramsey Ghaleb , Abdelrahman M. Elhusseiny , Muhammad Z. Chauhan , Joseph Toma , Tony Wang , Daniel Cheng , Asim Ali , Ahmed B. Sallam","doi":"10.1016/j.survophthal.2025.02.004","DOIUrl":"10.1016/j.survophthal.2025.02.004","url":null,"abstract":"<div><div>Cocaine, a prevalent drug of abuse, is associated with numerous systemic health complications, including significant ocular manifestations. These ocular effects range from mild to severe, with the potential for irreversible vision loss. Despite the extensive documentation of cocaine's systemic effects, the literature still lacks a focused review of its ocular manifestations. We methodically explore the epidemiology, pathophysiology, clinical presentations, diagnostic challenges, and therapeutic approaches related to cocaine-associated ocular manifestations. By categorizing the findings based on the anatomical location and type of pathology—orbital, corneal, retinal, neuro-ophthalmic, glaucoma-related, and uveal manifestations—we aim to provide a detailed overview that aids in early diagnosis and effective management of ocular disease secondary to cocaine use. Our review highlights the importance of awareness among clinicians, showcasing the wide range of ocular pathology to improve patient outcomes and prevent long-term ocular damage after cocaine abuse.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 4","pages":"Pages 825-832"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis 治疗增生性玻璃体视网膜病变的药物：一项系统综述和网络荟萃分析。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-01 DOI: 10.1016/j.survophthal.2025.02.005

Sina Khosravi Mirzaei MD , Firouze Hatami MD , Sare Safi PhD , Zahra Khorrami PhD , Fatemeh Khosravi Shadmani PhD , Seyed Mohamadmehdi Moshtaghion MD , Hamid Ahmadieh MD

{"title":"Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis","authors":"Sina Khosravi Mirzaei MD , Firouze Hatami MD , Sare Safi PhD , Zahra Khorrami PhD , Fatemeh Khosravi Shadmani PhD , Seyed Mohamadmehdi Moshtaghion MD , Hamid Ahmadieh MD","doi":"10.1016/j.survophthal.2025.02.005","DOIUrl":"10.1016/j.survophthal.2025.02.005","url":null,"abstract":"<div><div>We performed a comprehensive systematic review and network meta-analysis (NMA) to assess the efficacy of pharmacological agents for the treatment of proliferative vitreoretinopathy (PVR) following retinal detachment (RD) surgery. A systematic search was performed across PubMed, Scopus, Web of Science, and Embase. Randomized and non-randomized controlled trials and comparative observational studies evaluating the effect of pharmacological agents in a clinical setting were included. The primary outcome was retinal reattachment rate, and secondary outcomes were PVR recurrence, reoperation, intraocular pressure (IOP), epiretinal membrane (ERM), and macular edema. A total of 23 studies with 1749 eyes were included. Twelve different drugs or drug combinations were assessed. The NMA was performed for retinal reattachment, PVR recurrence, and reoperation rate outcomes. Among the pharmacological agents analyzed, adjunctive therapy with 13-cis-retinoic acid (13-cis-RA) demonstrated a statistically significant improvement in retinal reattachment rates (RR=1.36, 95 % CI: 1–1.84) and a reduction in reoperation rates (RR=0.23, 95 % CI: 0.07–0.69) compared to the control group, while none of the other drugs had statistically significant results. Additionally, adjunctive therapy did not yield significant improvements in IOP, ERM, or macular edema, except for a reduction in macular edema associated with dexamethasone in one study. This systematic review and NMA indicate that most pharmacological agents could not significantly improve retinal reattachment, reduce PVR recurrence, or lower reoperation rates following RD surgery. 13-cis-RA was the only drug that showed a significant impact on lowering retinal detachment and reoperation rates. Further high-quality clinical trials are warranted to confirm these findings.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 4","pages":"Pages 633-644"},"PeriodicalIF":5.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Advancing ophthalmology with large language models: Applications, challenges, and future directions. 用大语言模型推进眼科：应用、挑战和未来方向。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-01 DOI: 10.1016/j.survophthal.2025.02.009

Qi Zhang, Shaopan Wang, Xu Wang, Changsheng Xu, Jiajun Liang, Zuguo Liu

引用次数: 0

The mirrored arterial dilemma. 镜像动脉困境。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-02-28 DOI: 10.1016/j.survophthal.2025.02.006

Skenda Jean-Charles, Marissa K Shoji, Don O Kikkawa, M Tariq Bhatti

引用次数: 0

Social media in ophthalmology: A comprehensive literature review 眼科学中的社交媒体：综合文献综述。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-02-22 DOI: 10.1016/j.survophthal.2025.02.003

Jennifer K. Dunnigan BS , Celeste Y. Wang BA , Livia George BS , Virginia A. Lee , Kevin E. Lai MD , Andrew R. Carey MD , Andrew G. Lee MD

引用次数: 0

Clinical strategies to prevent recurrence of Herpes simplex and Herpes zoster following ocular surgery: A comprehensive review with practical guidelines 预防眼部手术后单纯疱疹和带状疱疹复发的临床策略：具有实用指南的综合综述。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-02-15 DOI: 10.1016/j.survophthal.2025.02.002

Sadegh Ghafarian , Bijan Samavat , Karen Lee , Sima Sheikhghomi , Kasra Cheraghpour , Deepak Shukla , Ali R. Djalilian , James Chodosh , Mohammad Soleimani

引用次数: 0

If at first you don’t succeed, try, try again 如果第一次不成功，就努力，再努力。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-02-14 DOI: 10.1016/j.survophthal.2025.01.011

Kambiz Ameli , Jacqueline M. Ihinger , Michael S. Lee , Andrew R. Carey

引用次数: 0

The applications of viscoelastic agents in vitreoretinal surgery 粘弹性剂在玻璃体视网膜手术中的应用。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-02-12 DOI: 10.1016/j.survophthal.2025.02.001

Matteo Mario Carlà MD, FEBO , Federico Giannuzzi MD, FEBO , Francesco Boselli MD, FEBO , Carlos Mateo MD , Tomaso Caporossi MD, PhD , Stanislao Rizzo MD

{"title":"The applications of viscoelastic agents in vitreoretinal surgery","authors":"Matteo Mario Carlà MD, FEBO , Federico Giannuzzi MD, FEBO , Francesco Boselli MD, FEBO , Carlos Mateo MD , Tomaso Caporossi MD, PhD , Stanislao Rizzo MD","doi":"10.1016/j.survophthal.2025.02.001","DOIUrl":"10.1016/j.survophthal.2025.02.001","url":null,"abstract":"<div><div>The introduction of viscoelastics in human ocular surgery dates back to 1972.Subsequntly, several substances were proposed as adjuvants, particularly for cataract surgery; however, the rheologic properties of ophthalmic viscosurgical devices (OVDs), such as viscosity, pseudoplasticity, and coatability led to their employment also in vitreoretinal surgery. OVDs can be used to separate tissues and create space, to break adhesions, to allow space for surgical manipulation, and to contain hemorrhage by dampening capillary oozing. We focus on the principles and clinical results of several viscosurgery techniques, such as viscodissection and viscodelamination for the management of proliferative vitreoretinopathy and diabetic retinopathy and suprachoroidal buckling for primary retinal detachment. Furthermore, we analyze the techniques in which OVDs served as adjuvants in macular hole surgery, particularly in the handling of the internal limiting membrane, and as volumetric substances against hypotony. Finally, we analyze recent perspectives on vitreous humor biochemical features. Preclinical research led to the belief that hyaluronic acid-based hydrogels could become ideal vitreous substitutes, thanks to their viscoelasticity, porosity, optical properties, and biocompatibility; however, although promising, long-term toxicity issues have limited studies on human subjects.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 4","pages":"Pages 713-724"},"PeriodicalIF":5.1,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143425984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids 中枢性浆液性脉络膜视网膜病变的药理学关联：超越皮质类固醇。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-02-09 DOI: 10.1016/j.survophthal.2025.01.017

Manish Jain , Arthi Mohankumar , Jairo Torres , Hamad A. Alkorbi

{"title":"Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids","authors":"Manish Jain , Arthi Mohankumar , Jairo Torres , Hamad A. Alkorbi","doi":"10.1016/j.survophthal.2025.01.017","DOIUrl":"10.1016/j.survophthal.2025.01.017","url":null,"abstract":"<div><div>Central serous chorioretinopathy (CSCR) has multiple associations and risk factors. Of these, psychological stress, corticosteroid treatment, and specific personality traits are well recognized. Other drugs, such as sympathomimetic agents, psychotropic drugs and phosphodiesterase inhibitors, are frequently incriminated. Male preponderance and higher incidence among pregnant and menopausal women give credence to a role of gonadal hormones; however, the acceptance or rejection of the proposed role of other drugs remains challenging due to paucity of data resulting from low usage. Despite presence of multiple risk factors in several patients, a large proportion remains idiopathic. We reviewed all such drugs, including sympathomimetic drugs, psychotropic drugs and recreational agents, phosphodiesterase inhibitors, gonadal hormones and analogues, vasopressin, minoxidil, follistatin, fingolimod, topiramate, muscle relaxants, and vaccines. The mechanisms and adverse event profile of these drugs suggest multiple ways such as alteration of hypothalamic-pituitary-adrenal axis, cortisol surge, activation of sympathetic nervous system, nitric-oxide synthetase, proinflammatory cytokines, complement factor F, Cytochrome P450 3A4, voltage gated ion channels, connexins and neurotransmitters that eventually contribute to CSCR. A common denominator, however, is the systemic and choroidal hemodynamic changes. A detailed medication history can unravel the modifiable risk factors in idiopathic CSCR; this history must include drugs that alter the clearance of other drugs and hormones via the cytochrome P450–3A4 system.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 4","pages":"Pages 616-632"},"PeriodicalIF":5.1,"publicationDate":"2025-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0